Furthermore, after removing SNPs with MACH Rsq ! 0.3, accuracy for both rare and low frequency SNPs was very high and almost identical to accuracy for common SNPs. We found that imputation using the 1KG-EUR panel had advantages in successfully imputing rare, low frequency and common variants. Our findings suggest that 1KG-based imputation can increase the opportunity to discover significant associations for SNPs across the allele frequency spectrum. Because the 1KG Project is still underway, we expect that later versions will provide even better imputation performance.
Introduction
Genome-wide association (GWA) studies and metaanalyses have been successful in discovering common variants influencing many complex traits (http://www. genome.gov/gwastudies/) [1] . Genotype imputations provide inferences of untyped markers in a study sample by using the linkage disequilibrium among markers present in an outside reference panel, such as those from the HapMap Project. The public data from the International HapMap Consortium [2] provides over 3.1 million SNPs across populations. Typical GWA studies directly genotype fewer SNPs than HapMap SNPs and impute the untyped markers that were present in the HapMap panel [3, 4] . Therefore, imputation provides a Performance of Genotype Imputations Using Data from the 1KG Project Hum Hered 2012;73:18-25 19 higher resolution of association regions and can boost power when compared to using only the genotyped SNPs [5, 6] . Furthermore, when different studies use different genotyping platforms, imputation with a common set of SNPs, such as the HapMap reference panel, makes it possible for different studies to be used in metaanalysis (e.g. [7] ).
Most imputations have used HapMap Phase II (HMII) data as a reference panel using several programs such as IMPUTE [8] , MACH [9] [10] [11] , BIMBAM [12] or BEAGLE [13, 14] . However, data from the 1000 Genomes (1KG) Project recently became available and provide a higher resolution of human genome sequence variation [15] . Using 1KG data as the reference panel, more genetic variants in GWA studies can be imputed than using HapMap data. Several recent papers have used 1KG data for imputation [16] . Using 1KG-based imputations with MACH, Sanna et al. [17] discovered association of CBLB gene variants with multiple sclerosis. Similarly using 1KG-based imputations with IMPUTE, Liu et al. [18] confirmed an effect on smoking quantity at a locus on 15q25. Using 1KG-based imputations, these and other investigations were able to observe stronger associations with SNPs that were not available in HMII data.
The major advantage of imputations based on the 1KG data, instead of the HapMap data, is the ability to impute a much larger number of SNPs. The 1KG Project aims to discover more than 95% of the variants with minor allele frequencies (MAF) as low as 0.01 across the genome and from 0.001 to 0.005 in gene regions [15] . Therefore, 1KG-based imputations should provide many more variants that are rare and low frequency than HapMap-based imputations. Browning [19] suggested that GWA studies using both imputed and observed genotypes increased the power for detecting rare causal variants. Li et al. [11, 20] also have shown that gain in power with imputation can be higher for rare variants than for common variants: for common variants (simulated MAF = 0.5) power slightly increased from 93.0 to 96.4%, whereas for rare variants (simulated MAF = 0.025) power dramatically increased from 24.4 to 56.2%. However, there are concerns about the data from the 1KG Project due to its potentially lower quality. The HapMap data were based on direct genotyping of previously discovered SNPs and have been thoroughly scrutinized, whereas currently available 1KG data were based on lowdepth whole-genome sequence data and, hence, are expected to be of lower quality. Furthermore, only limited evaluations of the performance of 1KG-based imputations are available [21, 22] .
In this paper, we empirically evaluated imputation performance using the 1KG data by comparing imputation results to those using the HMII data that have been widely used. Because the most used reference panel for imputing individuals of European ancestry is the CEU panel consisting of 120 haplotypes constructed from HMII data, we used two versions of reference panels constructed from the 1KG data. The CEU panel consisted of 120 haplotypes constructed from the 1KG sequencing data (June 2010 release) of the same 60 individuals as for CEU HapMap data. The EUR panel consisted of 566 haplotypes constructed from the 1KG sequencing data (August 2010 release) of 283 individuals of European ancestry. Due to the increased number of haplotypes of the EUR panel, it contains a substantially larger number of variants (11.4 million) than the other two panels. In particular, since both 1KG panels contain a large number of rare and low frequency variants, we investigated whether 1KG-based imputations provided good performance for these rare and low frequency variants.
Materials and Methods

Study Sample
We used Illumina 324,607 autosomal SNPs genotyped in 501 Caucasian individuals in the HERITAGE Family Study [23, 24] . The study recruited 503 Caucasian individuals from 99 nuclear families in the United States and Canada to investigate the genetic basis of cardiovascular and metabolic responses to exercise training. The participants were in good health and sedentary. GWA genotyping was performed using the Illumina HumanCNV370-Quad v3.0 BeadChips on Illumina BeadStation 500GX platform. The genotype calls were done with the Illumina GenomeStudio software and all samples were called in the same batch to eliminate batch-to-batch variation. Monomorphic SNPs and SNPs with only one heterozygote, as well as SNPs with more than 30% missing data were filtered out with GenomeStudio. Twelve samples were genotyped twice with 100% reproducibility across all SNPs. All GenomeStudio genotype calls with a GenTrain score ! 0.885 were checked and confirmed manually. Quality control of the GWA study SNP data confirmed all family relationships and found no evidence of DNA sample mix-ups. This study obtained informed consent from participants, and approval from the appropriate institutional review boards.
Reference Panels from the 1KG and HapMap
To impute individuals of European ancestry, we used 3 reference panels. The first panel, denoted by HMII-CEU , is the CEU reference panel consisting of 120 haplotypes constructed from HMII data (release 22, build 36) . The second panel, denoted by 1KG-CEU , is the CEU panel consisting of 120 haplotypes constructed from the 1KG sequencing data (June 2010 release) of the same 60 individuals as for HMII-CEU. The third panel, denoted by 1KG-EUR, is the EUR panel consisting of 566 haplotypes con-structed from the 1KG sequencing data (August 2010 release) of the 283 individuals of European ancestry. Both 1KG-CEU and 1KG-EUR were obtained from http://www.sph.umich.edu/csg/ abecasis/MACH/download/, as directed by the 1KG Project. The 1KG-EUR is the most recent QC-ed reference panel of European ancestry from the 1KG Project.
The HapMap Project aimed to discover common variants (MAF 1 0.05) and the HMII-CEU panel was constructed using genotype data of SNPs that were previously discovered. In contrast, the 1KG Project aims to discover rare (MAF ^ 0.01) and low frequency (0.01 ! MAF ^ 0.05) variants, and both 1KG-CEU and 1KG-EUR were constructed using low-depth whole-genome sequencing data, obtained with next-generation sequencers such as ABI's SOLiD, Roche's 454 and Illumina's Genome Analyzer. As shown in figure 1 , HMII-CEU, 1KG-CEU and 1KG-EUR contained 2.5 million, 6.8 million and 11.4 million SNPs, respectively. Most SNPs in HMII-CEU panel were also present in 1KG panels.
The 1KG data contained a much larger number of variants than the HapMap data across the MAF spectrum. With sequencing data, 1KG-CEU contained a large number of additional low frequency and common SNPs that were not present in HMII-CEU (shown in table 1 ). Furthermore, with sequencing data from more individuals, 1KG-EUR contained an even larger number of additional rare and low frequency SNPs that were not present in either HMII-CEU or 1KG-CEU.
Imputations Using MACH
In this paper, we used MACH [10, 11] because MACH and IMPUTE [8] , the two leading programs, have been shown to provide the most accurate results across various settings [25, 26] . Before imputation, the strand of GWA study SNPs that did not match with HapMap SNPs were flipped by using PLINK [27] . Following the developers' recommendation, we used a two-step procedure for running MACH (version 1.0.16). In the first step, the crossover map and error rate map were estimated using 50 rounds of iterations and 188 unrelated individuals. Then all subjects were used for genotype imputation in the second step. Imputations were performed separately by chromosomes.
To evaluate imputation performance, we masked 5, 25, 50 and 75% of SNPs in the HERITAGE GWA study. These masked SNPs were removed and imputation was performed using the remaining SNPs. Then the imputed results for these masked SNPs were compared with their real genotyped data to get imputation accuracy. To mask 5% of data, we removed an SNP in every 20th position in a physical map. Other masking was done similarly. We considered much higher masking rates than other papers that investigated imputation performance because we wanted to assess imputation performance for less desirable conditions, in particular, using the 1KG data. Most remaining SNPs that were used for imputation were present in all three reference panels ( table 2 ) . This is expected because most Illumina SNPs genotyped for the HERITAGE individuals were selected from HapMap SNPs. The panel 1KG-EUR contained a slightly smaller number of GWA SNPs than 1KG-CEU (317,110 vs. 320,366), although it included almost twice as many SNPs as shown in table 1 . We observed that most of these differences occurred because the two panels sometimes used different rs IDs when there were multiple rs IDs at the same position.
To evaluate imputation performance, we used imputation yield and accuracy for each imputed data set and concordance among the three reference panels. Following the developers' recommendation, we applied a filtering rule that removed monomorphic SNPs and SNPs with MACH's quality measure Rsq ! 0.3. Hence, non-monomorphic SNPs with Rsq 6 0.3 were considered as successfully imputed SNPs with appropriate quality. This also corresponds to the current common practice for numerous imputed data sets that were used in GWA and meta-analysis published papers. We defined imputation yield as the number of filtered SNPs that remained after removing SNPs with low imputation quality measures. We measured imputation accuracy using dosage Rsq: the squared correlation between the true genotype and continuousvalued imputed genotype dosage for each masked SNP. Concordance rates between true and imputed genotype calls are often very high for rare and low frequency SNPs and it is hard to compare imputation accuracy across SNPs with different MAFs. On the other hand, dosage Rsq is not confounded by MAF and can be used to compare accuracy for rare and common SNPs. We computed imputation accuracy for each panel using the mean of dosage Rsq values at filtered SNPs. Imputation accuracy was stratified within each MAF bin (rare, low frequency and common SNPs). To evaluate the effect of the filtering rule, we also computed accuracy using the mean of dosage Rsq values at all imputed SNPs.
HMII-CEU
Results
Imputation Yield across the MAF Spectrum
Imputations using 1KG data provided significantly higher yield (the number of filtered SNPs) than imputa- * SN Ps also in reference panels correspond to the remaining HERITAGE SNPs that are used for imputation. V alues in bold denote the highest accuracy rates for each masked data set. tions using HapMap data. Table 3 shows overall yield and yields across the MAF spectrum for all four masked data sets. Figure 2 also shows the total number of imputed SNPs in gray color. Imputation yield was highest with 1KG-EUR, next highest with 1KG-CEU and lowest with HMII-CEU for most masking rates. For the 5% masked data, which corresponded to a typical imputation scenario, imputation yield was 2.5 million, 6.0 million and 6.7 million SNPs using HMII-CEU, 1KG-CEU and 1KG-EUR, respectively. In particular, for 1KG-EUR, only 6.7 million (out of 11.5 million) SNPs were classified as successfully imputed, with 4.7 million SNPs being filtered out ( fig. 2 ). As expected, imputation yield dropped with higher masking rates. However, imputation yield dropped only slightly even for the 50% masked data (2.4 million, 5.4 million and 5.6 million SNPs). Decrease in imputation yield became significant only for the 80% masked data (2.1 million, 3.9 million and 3.6 million SNPs). This indicates a high tagging property of Illumina 330,000 SNPs because with 50% masking over 94% of SNPs in the HMII-CEU were successfully imputed. For 50% and higher masking rates, 1KG-CEU provided higher imputation yield than 1KG-EUR. Imputation using 1KG-EUR provided the highest yield for rare and low frequency variants for most masking rates ( figure 2 ; table 3 ). Improvement in imputation yield of 1KG-EUR over the other two panels was different across MAF spectrum. For 5% masked data, imputation using 1KG-EUR provided more than twice as many common SNPs as HMII-CEU (5.1 million vs. 2.1 million), four times as many low frequency SNPs (1.2 million vs. 0.3 million), and eight times as many rare SNPs (0.39 million vs. 0.05 million). Imputation yield using 1KG-CEU was similar to that using 1KG-EUR for common and low frequency SNPs. We expect that with non-masked data, an even larger number of rare and low frequency SNPs would be successfully imputed using the 1KG-EUR panel. However, imputation using 1KG-EUR provided 4.7 million SNPs that were classified as poorly imputed because they had MACH Rsq ! 0.3. Among these, 3.4 million were rare SNPs. With higher masking rates, imputation yield decreased more for rare and low frequency SNPs (see online supplementary figure 1, www. karger.com/doi/10.1159/000334084).
Imputation Accuracy across the MAF Spectrum
Overall imputation accuracy, the mean of dosage Rsq values at all imputed SNPs, using both 1KG panels was high and almost identical to the accuracy using the HMII-CEU panel for most masking rates. Table 4 shows accuracy before filtering (across all imputed SNPs) and after filtering (across filtered SNPs) for all masked data. Imputation yield (left) and accuracy (right) across the MAF spectrum for the 5% masked data using the three reference panels. Colored bars show yield and accuracy using filtered SNPs. Gray bars show total number of imputed SNPs and accuracy using all imputed SNPs. Online supplementary figure 1 shows the same information for all masked data. Figure 2 shows accuracy before filtering (in gray) and after filtering (in color) for the 5% masked data. Before filtering, accuracy rates were 87.5, 86.8 and 87.5% using HMII-CEU, 1KG-CEU and 1KG-EUR, respectively, for the 5% masked data. Accuracy for common SNPs was similar to overall accuracy. Accuracy for rare variants was highest with HMII-CEU (61%), lowest with 1KG-CEU (35%) and in the middle with 1KG-EUR (54%). After filtering SNPs with MACH Rsq ! 0.3, imputation with 1KG-EUR provided the highest imputation accuracy (90.7%). Accuracy was slightly lower with HMII-CEU and 1KG-CEU (88.6 and 88.9%). In particular, accuracy with 1KG-EUR was much improved for rare and low frequency variants (54 and 90% before and after filtering for the 5% masked data). Patterns were very similar across levels of masking ( table 3 ; online suppl. fig. 1 ). This is very surprising because accuracy using HMII-CEU or 1KG-CEU was not improved nearly as much by the filtering rule.
We investigated why these three reference panels behaved differently with the same filtering rule. A possible explanation for their different behavior is shown in figure  3 . The MACH Rsq value is supposed to be an unbiased estimate of the true dosage Rsq value, but this does not seem to be the case for the 1KG reference panels. The black line in the three panels is what the regression line would be if the MACH Rsq was actually unbiased. The magenta line is the actual regression line and the difference between the two is bias. Though there is little bias with the HMII-CEU, there is more with 1KG-CEU and still more with 1KG-EUR. Using the rule of removing SNPs with MACH Rsq ! 0.3 with the 1KG-EUR reference panel approximately corresponded to removing SNPs with true dosage Rsq ! 0.5. Because accuracy corresponds to the mean of dosage Rsq values at the filtered SNPs, this may account for the better performance of this filtering rule. This bias increased with higher masking rates.
Discussion
In this paper, we evaluated the performance of genotype imputations using the 1KG Project data, relative to imputations using the HMII data. Our most important finding was that both 1KG reference panels (1KG-CEU and 1KG-EUR) provided much higher imputation yield than the HMII panel. In particular, there were more than twice as many successfully imputed SNPs using 1KG-EUR as there were using HMII data (6.7 million vs. 2.5 million). There were twice as many common SNPs as HMII-CEU (5.1 million vs. 2.1 million), four times as many low frequency SNPs (1.2 million vs. 0.3 million), and eight times as many rare SNPs (0.39 million vs. 0.05 million). Our second most important finding was that ac- curacy using both 1KG panels was high and almost identical to the accuracy using the HMII-CEU panel. Furthermore, after removing SNPs with MACH Rsq ! 0.3, accuracy for both rare and low frequency SNPs was very high and almost identical to accuracy for common SNPs. Despite much higher SNP density, we expected the 1KG-based imputations to be of lower quality than HapMap-based imputations, due to low depth in terms of sequencing read depths (average of 4.6! in CEU). Our results were somewhat consistent in this regard in that 1KG-based imputations had a large fraction of SNPs with MACH Rsq ! 0.3. However, because the 1KG data contained a substantially larger number of SNPs, there were twice as many retained SNPs using the 1KG data as using the HapMap data. Furthermore, we observed that MACH Rsq values were consistently underestimating true dosage Rsq values for SNPs from 1KG-based imputations. As a consequence, accuracy of retained SNPs was highest with 1KG-based imputations.
We investigated whether using data from the 1KG has any advantage in terms of successfully imputing a large number of rare and low frequency variants. First, we found that rare variants in general had lower MACH Rsq values and were classified as poorly imputed. This was more obvious using the 1KG data. Our findings are consistent with other investigations [25, 28] which showed that rare variants were more difficult to tag than common SNPs and also confirm that imputation programs often perform poorly when imputing rare variants. Second, we found that imputations using 1KG-EUR had an advantage in imputing rare and low frequency variants. Our findings are consistent with those of Jostins et al. [29] , who showed that HapMap3-based imputations provided highly accurate imputation of low frequency variants due to large and diverse reference sets [30] . Imputation using 1KG-CEU also had an advantage in imputing low frequency variants. Furthermore, we found that using both 1KG-CEU and 1KG-EUR had a big advantage in imputing a large number of common variants. Our findings suggest that imputation using data from the 1KG can increase the opportunity to discover significant associations for SNPs across the whole MAF spectrum.
In this paper, we used two versions of the 1KG Project Pilot 1 data. We emphasize here that even though these 1KG reference panels were based on low-depth sequence data, to better handle low-depth sequence data, these panels were constructed using three independently developed methods that combine sequence data across samples and HapMap3 data: (1) QCALL [31] ; (2) Thunder [22] , and (3) DePristo et al. [32] using Genome Analysis Toolkit (GATK) [33] and BEAGLE [13, 14] . Furthermore, the 1KG Project is still underway, and genotype accuracy will be further improved due to increased sample sizes and a plan to directly genotype variants observed in the low-depth sequencing data. We expect that later versions will provide even better imputation performance.
